{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:34:13Z","timestamp":1787502853935,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.redox.2025.103538","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T11:34:30Z","timestamp":1739014470000},"page":"103538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Complex I superoxide anion production is necessary and sufficient for complex I inhibitor-induced dopaminergic neurodegeneration in Caenorhabditis elegans"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-2114","authenticated-orcid":false,"given":"Katherine S.","family":"Morton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel N.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"82","key":"10.1016\/j.redox.2025.103538_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-biochem-070511-103700","article-title":"Mitochondrial complex I","volume":"82","author":"Hirst","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.redox.2025.103538_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(91)90311-T","article-title":"Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease","volume":"104","author":"Bindoff","year":"1991","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.redox.2025.103538_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.redox.2025.103538_bib6","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.neurobiolaging.2015.05.008","article-title":"Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo","volume":"36","author":"Kim","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"7886","key":"10.1016\/j.redox.2025.103538_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.redox.2025.103538_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.25441","article-title":"Concordance for Parkinson's disease in twins: a 20-year update","volume":"85","author":"Goldman","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2025.103538_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"Goldman","year":"2014","journal-title":"Environmental Toxins and Parkinson's Disease. Annual Review of Pharmacology and Toxicology"},{"issue":"22","key":"10.1016\/j.redox.2025.103538_bib10","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","article-title":"Exposure to pesticides or solvents and risk of Parkinson disease","volume":"80","author":"Pezzoli","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.redox.2025.103538_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/10408444.2013.798719","article-title":"Parkinson's disease and pesticide exposure\u2013a new assessment","volume":"43","author":"Allen","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"issue":"7","key":"10.1016\/j.redox.2025.103538_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","article-title":"Permanent human parkinsonism due to 1\u2010methy 1\u20134\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine (MPTP)","volume":"35","author":"Ballard","year":"1985","journal-title":"Neurology"},{"issue":"4587","key":"10.1016\/j.redox.2025.103538_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0003-9861(87)90531-5","article-title":"The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase","volume":"259","author":"Ramsay","year":"1987","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-291X(86)80483-1","article-title":"Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+","volume":"134","author":"Ramsay","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.redox.2025.103538_bib16","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s10072-021-05551-1","article-title":"A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"42","author":"Mani","year":"2021","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41531-023-00561-6","article-title":"Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy","volume":"9","author":"Van Laar","year":"2023","journal-title":"npj Parkinson's Disease"},{"issue":"12","key":"10.1016\/j.redox.2025.103538_bib18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib19","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41467-024-47867-4","article-title":"Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease","volume":"15","author":"Fl\u00f8nes","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103538_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147434","article-title":"Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal","volume":"1767","author":"Subrahmanian","year":"2021","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.redox.2025.103538_bib21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41386-018-0090-0","article-title":"Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease","volume":"44","author":"Holper","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.redox.2025.103538_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ana.24014","article-title":"Energy failure","volume":"74","author":"Pathak","year":"2013","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1471-4159.1994.63020640.x","article-title":"Effects of 1\u2010methyl\u20104\u2010phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion","volume":"63","author":"Bates","year":"1994","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.redox.2025.103538_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1471-4159.2012.07836.x","article-title":"Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation","volume":"122","author":"Dranka","year":"2012","journal-title":"J. Neurochem."},{"issue":"34","key":"10.1016\/j.redox.2025.103538_bib25","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.redox.2025.103538_bib26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","article-title":"Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease","volume":"100","author":"Sherer","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2025.103538_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pneurobio.2015.10.005","article-title":"Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: methylene blue connects the dots","volume":"157","author":"Yang","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41531-023-00615-9","article-title":"Towards improved screening of toxins for Parkinson's risk","volume":"9","author":"Shan","year":"2023","journal-title":"npj Parkinson's Disease"},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2009.08.004","article-title":"Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies","volume":"220","author":"H\u00f6llerhage","year":"2009","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chembiol.2021.11.002","article-title":"Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I","volume":"29","author":"Jain","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2025.103538_bib32","series-title":"Clinical Bioenergetics","first-page":"327","article-title":"Chapter 14 - targeting respiratory complex I\u2014molecular mechanism and drug design","author":"Sharma","year":"2021"},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0005-2728(98)00034-6","article-title":"Complex I inhibitors as insecticides and acaricides","volume":"1364","author":"L\u00fcmmen","year":"1998","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1042\/bst0220230","article-title":"New inhibitors of complex I of the mitochondrial electron transport chain with activity as pesticides","volume":"22","author":"Hollingworth","year":"1994","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0005-2728(98)00030-9","article-title":"Structure\u2013activity relationships of some complex I inhibitors","volume":"1364","author":"Miyoshi","year":"1998","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0005-2728(98)00029-2","article-title":"Inhibitors of NADH\u2013ubiquinone reductase: an overview","volume":"1364","author":"Degli","year":"1998","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"5","key":"10.1016\/j.redox.2025.103538_bib37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbabio.2008.11.003","article-title":"Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species","volume":"1787","author":"Fato","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2025.103538_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101722","article-title":"Production of superoxide and hydrogen peroxide in the mitochondrial matrix is dominated by site IQ of complex I in diverse cell lines","volume":"37","author":"Fang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103538_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101341","article-title":"The use of site-specific suppressors to measure the relative contributions of different mitochondrial sites to skeletal muscle superoxide and hydrogen peroxide production","volume":"28","author":"Goncalves","year":"2020","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.redox.2025.103538_bib40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbabio.2015.12.009","article-title":"Energy conversion, redox catalysis and generation of reactive oxygen species by respiratory complex I","volume":"1857","author":"Hirst","year":"2016","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.redox.2025.103538_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.freeradbiomed.2013.04.021","article-title":"Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: distinct roles of superoxide anion and superoxide dismutases","volume":"61","author":"Rodriguez-Rocha","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103538_bib42","author":"Petitjean","year":"2023","journal-title":"United States"},{"issue":"5","key":"10.1016\/j.redox.2025.103538_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216385","article-title":"An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals","volume":"14","author":"Detaille","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.redox.2025.103538_bib44","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1570159X13666151030102718","article-title":"Anti-oxidants in Parkinson's disease therapy: a critical point of view","volume":"14","author":"Filograna","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10030453","article-title":"Antioxidant therapeutics in Parkinson's disease: current challenges and opportunities","volume":"10","author":"Duarte-Jurado","year":"2021","journal-title":"Antioxidants"},{"issue":"18","key":"10.1016\/j.redox.2025.103538_bib47","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1111\/j.1742-4658.2007.06004.x","article-title":"Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding","volume":"274","author":"Srivastava","year":"2007","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.redox.2025.103538_bib48","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.201009132","article-title":"Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model","volume":"192","author":"Choi","year":"2011","journal-title":"JCB (J. Cell Biol.)"},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12915-023-01733-9","article-title":"Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration","volume":"21","author":"Morton","year":"2023","journal-title":"BMC Biol."},{"issue":"64","key":"10.1016\/j.redox.2025.103538_bib50","doi-asserted-by":"crossref","DOI":"10.3791\/4019-v","article-title":"Basic Caenorhabditis elegans methods: synchronization and observation","author":"Porta-de-la-Riva","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"25.8.1-.8.2","key":"10.1016\/j.redox.2025.103538_bib51","article-title":"In vivo determination of mitochondrial function using luciferase-expressing Caenorhabditis elegans: contribution of oxidative phosphorylation, glycolysis, and fatty acid oxidation to toxicant-induced dysfunction","volume":"69","author":"Luz","year":"2016","journal-title":"Curr Protoc Toxicol"},{"key":"10.1016\/j.redox.2025.103538_bib52","unstructured":"Bijwadia SR, Morton KS, Meyer JN. Quantifying levels of dopaminergic neuron morphological alteration and degeneration in Caenorhabditis elegans. JoVE J.e62894."},{"issue":"23","key":"10.1016\/j.redox.2025.103538_bib53","doi-asserted-by":"crossref","first-page":"e3103","DOI":"10.21769\/BioProtoc.3103","article-title":"Blinded visual scoring of images using the freely-available software blinder","volume":"8","author":"Cothren","year":"2018","journal-title":"Bio-protocol"},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib54","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41467-022-30169-y","article-title":"A reversible mitochondrial complex I thiol switch mediates hypoxic avoidance behavior in C. elegans","volume":"13","author":"Onukwufor","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103538_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2019.12.008","article-title":"Quantification of reactive oxygen species production by the red fluorescent proteins KillerRed, SuperNova and mCherry","volume":"147","author":"Onukwufor","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103538_bib56","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.freeradbiomed.2020.12.022","article-title":"Singlet oxygen stimulates mitochondrial bioenergetics in brain cells","volume":"163","author":"Sokolovski","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0896-6273(00)81199-X","article-title":"Elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway","volume":"26","author":"Sawin","year":"2000","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-212922","article-title":"Preventing Parkinson's disease: an environmental agenda","volume":"12","author":"De Miranda","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2025.103538_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","article-title":"An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene\u2013environment interactions","volume":"46","author":"Johnson","year":"2015","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib61","article-title":"Modification of the existing maximum residue level for pyridaben in sweet pepper\/bell pepper and setting of an import tolerance in tree nuts","volume":"18","author":"Authority","year":"2020","journal-title":"EFSA J."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00204-019-02636-x","article-title":"Concentration-response evaluation of ToxCast compounds for multivariate activity patterns of neural network function","volume":"94","author":"Kosnik","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.redox.2025.103538_bib63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00204-020-02970-5","article-title":"Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors","volume":"95","author":"Delp","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.redox.2025.103538_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036191","article-title":"Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease","volume":"7","author":"Gollamudi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2025.103538_bib65","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuro.2015.06.007","article-title":"Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model","volume":"53","author":"Charli","year":"2016","journal-title":"Neurotoxicology"},{"issue":"7","key":"10.1016\/j.redox.2025.103538_bib66","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1073\/pnas.96.7.4149","article-title":"NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron\u2013sulfur cluster N2 to quinone","volume":"96","author":"Schuler","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ntt.2008.12.004","article-title":"Medium- and high-throughput screening of neurotoxicants using C. elegans","volume":"32","author":"Boyd","year":"2010","journal-title":"Neurotoxicol. Teratol."},{"issue":"52","key":"10.1016\/j.redox.2025.103538_bib68","doi-asserted-by":"crossref","first-page":"42655","DOI":"10.1074\/jbc.M505910200","article-title":"Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of \u03b1-synuclein, Parkin, and DJ-1 in Caenorhabditis elegans","volume":"280","author":"Ved","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103538_bib69","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.redox.2017.04.038","article-title":"Constitutive activation of Nrf2 induces a stable reductive state in the mouse myocardium","volume":"12","author":"Shanmugam","year":"2017","journal-title":"Redox Biol."},{"issue":"6218","key":"10.1016\/j.redox.2025.103538_bib70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1260451","article-title":"Structural biology. Division of labor in transhydrogenase by alternating proton translocation and hydride transfer","volume":"347","author":"Leung","year":"2015","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.redox.2025.103538_bib71","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.freeradbiomed.2005.02.012","article-title":"A Caenorhabditis elegans mutant lacking functional nicotinamide nucleotide transhydrogenase displays increased sensitivity to oxidative stress","volume":"38","author":"Arkblad","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.redox.2025.103538_bib72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cmet.2016.08.012","article-title":"Suppressors of superoxide-H(2)O(2) production at site I(Q) of mitochondrial complex I protect against stem cell hyperplasia and ischemia-reperfusion injury","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.redox.2025.103538_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114459","article-title":"Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans","volume":"9","author":"Gonz\u00e1lez-Hunt","year":"2014","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.redox.2025.103538_bib74","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3390\/ijms20133202","article-title":"Genetic defects in mitochondrial dynamics in Caenorhabditis elegans impact ultraviolet C radiation- and 6-hydroxydopamine-Induced neurodegeneration","volume":"20","author":"Hartman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103538_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2022.100084","article-title":"Mild pentachlorophenol-mediated uncoupling of mitochondria depletes ATP but does not cause an oxidized redox state or dopaminergic neurodegeneration in Caenorhabditis elegans","volume":"3","author":"Markovich","year":"2022","journal-title":"Curr Res Toxicol"},{"key":"10.1016\/j.redox.2025.103538_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.615461","article-title":"Targeting mitochondrial impairment in Parkinson's disease: challenges and opportunities","volume":"8","author":"Prasuhn","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.redox.2025.103538_bib77","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib78","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","article-title":"LRRK2 and idiopathic Parkinson's disease","volume":"45","author":"Rocha","year":"2022","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/toxsci\/kfx117","article-title":"Editor's highlight: nlrp3 is required for inflammatory changes and nigral cell loss resulting from chronic intragastric rotenone exposure in mice","volume":"159","author":"Martinez","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.redox.2025.103538_bib80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00204-017-2133-4","article-title":"An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition","volume":"92","author":"Terron","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.redox.2025.103538_bib81","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/10409238.2020.1828258","article-title":"Riding the tiger - physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix","volume":"55","author":"Brand","year":"2020","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"16","key":"10.1016\/j.redox.2025.103538_bib82","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1074\/jbc.RA119.007687","article-title":"Defining the mechanism of action of S1QELs, specific suppressors of superoxide production in the quinone-reaction site in mitochondrial complex I","volume":"294","author":"Banba","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.redox.2025.103538_bib83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radic. Biol. Med."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:53:42Z","timestamp":1742306022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":83,"alternative-id":["S2213231725000515"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103538","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex I superoxide anion production is necessary and sufficient for complex I inhibitor-induced dopaminergic neurodegeneration in Caenorhabditis elegans","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103538"}}